Cortex Pharmaceuticals, Inc. announced that James E. Sapirstein and Kathryn MacFarlane have joined the board of directors of the company as independent directors. James E. Sapirstein has been the Chief Executive Officer and director of ContraVir Pharmaceuticals, Inc. Ms. MacFarlane is currently an owner and Managing Partner of SmartPharma LLC.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | -6.25% | -10.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 744K | |
+7.66% | 111B | |
+11.09% | 106B | |
-12.29% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.61% | 16.81B | |
+38.92% | 12.54B | |
-24.71% | 8.09B |
- Stock Market
- Equities
- RSPI Stock
- News RespireRx Pharmaceuticals Inc.
- Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors